BioXcel Therapeutics, Inc. (BTAI) Stock Price History
Historical prices from 2018 to 2026
Loading 10-year price history...
BTAI Historical Performance
Short-Term Returns
BTAI Stock Price Trajectory (2018–2026)
As of May 8, 2026, BioXcel Therapeutics, Inc. (BTAI) trades at $1.24, representing a -19.0% return over the past year. The stock has delivered a -99.7% total return over five years (-69.7% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $1,144.00 on July 20, 2020. From this peak, BTAI has corrected -99.9%, currently trading 43% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers ACAD (+52.4% 1Y), INVA (+21.7% 1Y), and AXSM (+98.5% 1Y), BTAI has underperformed the peer group average. Compare BTAI vs ACAD →
BTAI Historical Price Data (2025–2026)
Showing 30 of 2,054 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 1.30 | 1.32 | 1.21 | 1.24 | 768K | -4.62% |
| 2026-05-06 | 1.28 | 1.37 | 1.24 | 1.30 | 890K | +4.00% |
| 2026-05-05 | 1.26 | 1.31 | 1.25 | 1.25 | 581K | -0.79% |
| 2026-05-04 | 1.21 | 1.29 | 1.20 | 1.26 | 811K | +5.00% |
| 2026-05-01 | 1.23 | 1.29 | 1.14 | 1.20 | 1.18M | -2.44% |
| 2026-04-30 | 1.07 | 1.25 | 1.06 | 1.23 | 1.41M | +18.27% |
| 2026-04-29 | 1.06 | 1.07 | 1.02 | 1.04 | 623K | -1.89% |
| 2026-04-28 | 1.10 | 1.10 | 1.05 | 1.06 | 473K | -2.75% |
| 2026-04-27 | 1.07 | 1.14 | 1.07 | 1.09 | 537K | +2.83% |
| 2026-04-24 | 1.10 | 1.10 | 1.06 | 1.06 | 477K | -3.64% |
| 2026-04-23 | 1.16 | 1.17 | 1.09 | 1.10 | 817K | -4.35% |
| 2026-04-22 | 1.16 | 1.23 | 1.13 | 1.15 | 857K | 0.00% |
| 2026-04-21 | 1.22 | 1.23 | 1.15 | 1.15 | 629K | -4.17% |
| 2026-04-20 | 1.12 | 1.21 | 1.12 | 1.20 | 802K | +2.56% |
| 2026-04-17 | 1.10 | 1.25 | 1.10 | 1.17 | 1.86M | +9.35% |
| 2026-04-16 | 1.07 | 1.09 | 1.01 | 1.07 | 1.16M | +1.90% |
| 2026-04-15 | 1.07 | 1.14 | 1.05 | 1.05 | 1.31M | -0.94% |
| 2026-04-14 | 1.01 | 1.07 | 1.01 | 1.06 | 766K | +3.92% |
| 2026-04-13 | 1.05 | 1.08 | 1.01 | 1.02 | 1.56M | -3.77% |
| 2026-04-10 | 1.10 | 1.11 | 1.05 | 1.06 | 772K | -1.85% |
| 2026-04-09 | 1.08 | 1.15 | 1.07 | 1.08 | 825K | -1.82% |
| 2026-04-08 | 1.16 | 1.18 | 1.08 | 1.10 | 1.33M | +0.92% |
| 2026-04-07 | 1.14 | 1.15 | 1.06 | 1.09 | 1.23M | -4.39% |
| 2026-04-06 | 1.21 | 1.22 | 1.13 | 1.14 | 882K | -3.39% |
| 2026-04-02 | 1.11 | 1.22 | 1.08 | 1.18 | 1.01M | -3.28% |
| 2026-04-01 | 1.38 | 1.42 | 1.19 | 1.22 | 3.12M | -8.96% |
| 2026-03-31 | 1.22 | 1.35 | 1.21 | 1.34 | 601K | +10.74% |
| 2026-03-30 | 1.28 | 1.28 | 1.15 | 1.21 | 879K | -3.97% |
| 2026-03-27 | 1.38 | 1.42 | 1.25 | 1.26 | 954K | -8.03% |
| 2026-03-26 | 1.41 | 1.44 | 1.35 | 1.37 | 516K | -4.20% |
See BTAI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BTAI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BTAI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBTAI — Frequently Asked Questions
Quick answers to the most common questions about buying BTAI stock.
How has BTAI stock performed recently?
BTAI declined -19.0% over the past year, below its 5-year annualized CAGR of -69.7%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is BTAI's all-time high price?
BioXcel Therapeutics, Inc. reached $1144.00 on 2020-07-20. The 52-week high is $8.08. Current 1-year return of -19.0% places the stock further from historical peaks.
Where can I download BTAI historical price data?
This page provides BTAI daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2018-2026, downloadable in CSV format.